See All Slides - tctmd.com

Slides

Presentation TCT 2012

Overview 1: Biological Therapies for Heart Failure: Clinical Perspectives and Progress

Presenter: Timothy Henry

October 23, 2012

Presentation TCT 2012

State-of-the-Field Keynote: The Next Challenge: Improving Technical Efficiency and Biological Response (Nonresponders)

Presenter: Deepak Bhatt

October 23, 2012

Presentation TCT 2012

TCT-585: Six-Month Results of the BIOLUX P-I First-in-Man Study Comparing a Paclitaxel-Releasing Balloon Catheter vs. an Uncoated Balloon Catheter in Femoropopliteal Lesions

Presenter: Dierk Scheinert

October 23, 2012

Presentation TCT 2012

Introduction(6)

Presenter: Rudiger Lange

October 23, 2012

Presentation TCT 2012

Management of the Device Patient for the Non-EP MD

Presenter: Ralph Verdino

October 23, 2012

Presentation TCT 2012

Introduction(11)

Presenter: Biykem Bozkurt

October 23, 2012

Presentation TCT 2012

Updated CRT Guidelines

Presenter: William Abraham

October 23, 2012

Presentation TCT 2012

Quality-of-Life and Cost-Effectiveness After LAA Closure

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

TCT-68. The Use of Percutaneous Left Ventricular Assist Device vs. Intra-aortic Balloon Pump for Hemodynamic Support During High Risk PCI

Presenter: William O'Neill

October 23, 2012

Presentation TCT 2012

What Will We Learn from the EXCEL Trial that We Do Not Already Know?

Presenter: Gregg Stone

October 23, 2012

Advertisement

Slides

Overview 1: Biological Therapies for Heart Failure: Clinical Perspectives and Progress

State-of-the-Field Keynote: The Next Challenge: Improving Technical Efficiency and Biological Response (Nonresponders)

TCT-585: Six-Month Results of the BIOLUX P-I First-in-Man Study Comparing a Paclitaxel-Releasing Balloon Catheter vs. an Uncoated Balloon Catheter in Femoropopliteal Lesions

Introduction(6)

Management of the Device Patient for the Non-EP MD

Introduction(11)

Updated CRT Guidelines

Quality-of-Life and Cost-Effectiveness After LAA Closure

TCT-68. The Use of Percutaneous Left Ventricular Assist Device vs. Intra-aortic Balloon Pump for Hemodynamic Support During High Risk PCI

What Will We Learn from the EXCEL Trial that We Do Not Already Know?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content